Stockpickr

Stockpickr Lists: Cypress Bioscience

 

Editor's Note: In this feature from Stockpickr , we highlight lists of stocks that have made new highs, lows or seen other unusual activity.

Biggest % Gainers: Cypress Bioscience(CYPB) rocketed 94% to $16.37, after CIBC World Markets upgraded the stock to outperform. The upgrade came a day after the company announced successful study results for an experimental drug for treating fibromyalgia syndrome, an illness causing chronic pain.

Rising on Unusual Volume. Cypress Bioscience's shares shot up on heavy trading. Volume was up 4,900% its average.

52-Week Highs: Cypress Bioscience's closing price also was a 52-week high.

Latest-Activist-Situations: Hedge fund Pirate Capital lowered its stake in aerospace and defense contractor GenCorp(GY) to 6.8%.

Biggest % Losers: Vion Pharmaceuticals(VION) dropped 56% to 86 cents after announcing the suspension of a late-stage trial for leukemia drug Cloretazine.

52-Week Lows: Northwestern(NWEC), an energy utility that does business in the Midwest and Northwestern U.S., dropped nearly 5.4% to $32.93, a 52-week low. The company's shares dropped after the Montana Public Service Commission opposed its sale to an Australian company.

Stocks with Unusual Option Activity: Kraft(KFT), which Altria spun off last quarter, was experiencing unusual options activity.

Forum of the Day

whitemagic asks, How do options actually get priced?

Do You Know the Answer?

Why was there a big selloff Wednesday afternoon?, birdman20083 asks.

Feeling Lucky?

And finally, try picking a random portfolio suited to do-it-yourselfers with more detailed analysis at I'm Feeling Lucky.

>To order reprints of this article, click here: Reprints

Stockpickr is a wholly owned subsidiary of TheStreet.com.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet